Exact FDA event identifier

Event 93703

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: December 29, 2023
Product types: Drug
Classifications: Class II
Statuses: Terminated
Recalling firm wording: Strides Pharma Inc.

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India. Distributed by:Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-752-16

D-0260-2024

Recall number: D-0260-2024
Initiated: December 29, 2023
Classification: Class II
Status: Terminated
Recalling firm: Strides Pharma Inc.
Quantity: 396 50-count bottles

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Failed Dissolution Specifications

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Dissolution Specifications

Code information

Lot #: 7253092B, Exp Date 09/30/2025

Distribution pattern

Nationwide in the USA